Is Egrifta (Tesamorelin) Legal in Oregon? How to Access It Legally
HealthRX.com
Egrifta is prescription-only and approved for one use
See the public record for Tesamorelin
At a glance
- Drug / Egrifta (tesamorelin acetate), a growth hormone-releasing factor analog peptide
- FDA approval / November 10, 2010, application BLA 022505 [1]
- Current labels / Egrifta SV (2 mg vial) and Egrifta WR (11.6 mg vial), both dated July 29, 2026 [2][4]
- Approved use / Excess abdominal fat in HIV-infected adults with lipodystrophy [2]
- Prescription status / Prescription-only; not indicated for weight loss, weight-neutral effect [1][2]
- Compounding / No category-based FDA statement; already part of an approved drug [5][6][7]
- Sport / Prohibited at all times under WADA S2.2.4 [8][9]
The federal position, briefly
Egrifta (tesamorelin acetate) was first approved on November 10, 2010 under application BLA 022505 [1]. Two labels are current: Egrifta SV, a 2 mg vial, and Egrifta WR, an 11.6 mg vial, both dated July 29, 2026 and both given as once-daily subcutaneous injections [2][4]. Tesamorelin is a synthetic analog of human growth hormone-releasing factor, a peptide rather than growth hormone itself [2].
The single approved use is reduction of excess abdominal fat in HIV-infected adult patients with lipodystrophy [2]. The label's limitations matter for anyone seeking it for another reason: long-term cardiovascular safety has not been established, it is not indicated for weight loss management because it has a weight-neutral effect, and there are no data that it improves adherence to antiretroviral therapy [2].
Where compounding stands
Tesamorelin does not appear on FDA's page of bulk substances that may present significant safety risks when compounded, content dated 04/22/2026 [5]. It also appears in no category of FDA's list for state-licensed pharmacies and physicians (updated May 14, 2026) or of FDA's list for outsourcing facilities (updated March 21, 2025) [6][7]. FDA has therefore made no category-based statement about compounding it, and it is already a component of an FDA-approved drug [5][6][7].
Tesamorelin is not one of the six peptides in HHS's draft enforcement-discretion policy for compounding, filed October 28, 2026; those six are BPC-157, epitalon, KPV, MOTS-c, Semax and TB-500 [10][11]. Absence from a restricted list is not approval: compounded drugs are not FDA-approved, and FDA does not review their safety, effectiveness or quality before they are marketed [10][11].
Sport rules that do name it
WADA's Prohibited List places tesamorelin in S2.2.4 among growth hormone releasing factors, prohibited at all times in and out of competition, and it appears on the 2026 List in force since January 1, 2026 and on the 2027 List [8][9].
What a prescription actually involves
Egrifta SV and Egrifta WR have different doses and are not substitutable [2][4].
The label asks prescribers to monitor IGF-1 and to evaluate glucose before and during treatment [2]. Among patients treated for 26 weeks, 47% had IGF-1 above 2 SDS and 36% above 3 SDS; HbA1c of 6.5% or higher developed in 5% of tesamorelin patients versus 1% on placebo by week 26, a hazard ratio of about 3.3 (95% CI 1.4 to 9.6) [2]. The label contraindicates the drug in disruption of the hypothalamic-pituitary axis, active malignancy, known hypersensitivity to tesamorelin or its excipients, and pregnancy [2][4].
Check what you know
Question 1 of 3
Score: 0 right, 0 of 3 answered
What people on Reddit report
Two posts from one forum thread about whether a specialist will prescribe tesamorelin and what getting it involves.
I have a follow up appointment with my endo about my TRT. I'm wondering if they can prescribe Tesamorelin? Or if anyone else had luck getting it from there specialist or there primary doc?Read the source discussion
Tesamorelin is FDA approved as Egrifta and Egrifta SV, but those are super expensive ($7k/mo) and you probably won't get a prescription unless you have lipodystrophy from HIV/antiretrovirals.Read the source discussion
Questions worth asking
Frequently asked questions
Is tesamorelin legal in Oregon?
Is compounded tesamorelin legal in Oregon?
Is tesamorelin approved for weight loss or anti-aging?
What dose do the current labels give?
Does WADA prohibit tesamorelin?
Reader questions
What people actually ask
Short answers drawn from the sources this article cites.
Can you legally compound tesamorelin?
FDA has made no category-based statement about compounding it. Tesamorelin is not on FDA's list of bulk substances that may present significant safety risks when compounded, and it appears in no category of FDA's compounding lists. Compounded drugs are not FDA-approved, and FDA does not review their safety, effectiveness or quality before they are marketed.
Can my endocrinologist doc prescribe Tesamorelin?
Tesamorelin is prescription-only, so it has to be prescribed by a prescriber. The label asks prescribers to monitor IGF-1 and to evaluate glucose before and during treatment. It is contraindicated in active malignancy, pregnancy, disruption of the hypothalamic-pituitary axis, and known hypersensitivity to tesamorelin or its excipients.
References
Show all 12 referencesHide references
- Drugs@FDA: FDA-Approved Drugs.
- U.S. National Library of Medicine, DailyMed. Egrifta SV (tesamorelin) for injection, 2 mg vial prescribing information. Egrifta SV (tesamorelin) for injection, 2 mg vial label
- Oregon State Legislature.
- U.S. National Library of Medicine, DailyMed. Egrifta WR (tesamorelin) for injection, 11.6 mg vial prescribing information. Egrifta WR (tesamorelin) for injection, 11.6 mg vial label
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks | FDA.
- U.S. Food and Drug Administration.
- U.S. Food and Drug Administration.
- World Anti-Doping Agency.
- World Anti-Doping Agency.
- Official web page.
- Official web page.
- Reddit participants. Can my endocrinologist doc prescribe Tesamorelin? (r/PeptideForum). Accessed 2026-11-11.